VAERS reports by lot

GSK DTaP/Tdap lot K5F5R: VAERS reports

26 VAERS reports list lot K5F5R as a GSK DTaP/Tdap vaccine, received between 2018-11-07 and 2021-08-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
4%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1921%
Injection-site / Local reaction1921%
Neurological1718%
Gastrointestinal1011%
Allergic / Anaphylactic89%
Musculoskeletal89%
Dermatological (non-injection-site)67%
Respiratory22%
Psychiatric / Neuropsychiatric22%
Cardiac / Cardiovascular11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois6
California3
Indiana2
Alabama2
Arizona1
Ohio1
South Carolina1
Florida1
Virginia1
Tennessee1
North Carolina1
Texas1

Reports by month received

2018-111
2018-122
2019-015
2019-022
2019-035
2019-043
2019-051
2019-071
2019-082
2019-091
2020-081
2021-082

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.